US Broker Ratings

Evotec SE (EVO) Stock Analysis: Unveiling a 53.82% Potential Upside Amidst Current Challenges

Evotec SE (EVO), a prominent player in the healthcare sector, operates within the specialty and generic drug manufacturing industry. Headquartered in Hamburg, Germany, Evotec SE is engaged in drug discovery..

Amicus Therapeutics (FOLD) Stock Analysis: Navigating Growth in Rare Disease Biotech

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is garnering attention in the biotechnology sector with its strategic focus on rare diseases, a niche that promises both potential growth and inherent challenges. With..

HUTCHMED (China) Limited (HCM): Investor Outlook on a Potential 41.74% Upside

HUTCHMED (China) Limited (NASDAQ: HCM) presents a compelling opportunity for investors seeking exposure to the dynamic healthcare sector, particularly in the realm of innovative cancer treatments. With a market capitalization..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: A 30% Upside Potential in the Biotech Sector

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a prominent player in the biotechnology sector, has been capturing investor attention with its remarkable growth trajectory and promising pipeline of RNAi-based therapies. With a..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Biotech Gem with 14% Upside Potential

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is making waves in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $6.02 billion, this U.S.-based company is focused on..

Acadia Healthcare (ACHC) Stock Analysis: Evaluating a 41% Upside Potential Amidst Strong Buy Ratings

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) presents itself as an intriguing opportunity for investors seeking exposure in the healthcare sector, particularly within the specialized realm of behavioral health services. With..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring a 106% Upside Potential Amid Healthcare Industry Dynamics

GoodRx Holdings, Inc. (NASDAQ: GDRX), a prominent player in the healthcare sector, is currently capturing investor attention with a substantial potential upside of over 106%. As the company navigates the..

Schrodinger, Inc. (SDGR) Stock Analysis: Unveiling an 83.82% Upside Potential

For investors with an eye on innovation within the healthcare sector, Schrodinger, Inc. (NASDAQ: SDGR) presents an intriguing opportunity. The New York-based company, with a market capitalization of $1 billion,..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 29.78% Upside Potential in the Diagnostics Sector

Veracyte, Inc. (NYSE: VCYT) stands out in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $2.9 billion, this South San Francisco-based company is..

National HealthCare Corporation (NHC) Stock Analysis: A Closer Look at Strong Revenue Growth Amidst Lack of Analyst Ratings

National HealthCare Corporation (NYSE: NHC), a prominent player in the healthcare sector, operates a diversified portfolio of medical care facilities across the United States. This company, with a robust market..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Exploring Value Amidst Challenges with a 4.67% Dividend Yield

DENTSPLY SIRONA Inc. (XRAY), a key player in the healthcare sector, particularly in medical instruments and supplies, is drawing investor attention with its robust 4.67% dividend yield despite facing several..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Exploring the 68% Potential Upside for Investors

Centessa Pharmaceuticals plc (NASDAQ: CNTA) is catching the attention of investors looking for high-growth opportunities within the healthcare sector. As a clinical-stage pharmaceutical company, Centessa is focused on discovering, developing,..

Brookdale Senior Living Inc. (BKD) Investor Outlook: Analyzing a 16.71% Potential Upside in the Healthcare Sector

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, specializes in managing senior living communities across the United States. With a market capitalization of $3.87 billion,..

Organon & Co. (OGN) Stock Analysis: Exploring a Potential 18.3% Upside in Healthcare

Organon & Co. (NYSE: OGN), a noteworthy player in the general drug manufacturing sector, presents an intriguing opportunity for investors interested in the healthcare landscape. With a market capitalization of..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Unveiling a 69.80% Potential Upside

CRISPR Therapeutics AG (NASDAQ: CRSP) stands at the forefront of genetic innovation with its cutting-edge CRISPR/Cas9 platform, targeting a vast array of serious human diseases. As individual investors evaluate their..

Harmony Biosciences Holdings, Inc. (HRMY): Investor Outlook Reveals a 25% Upside Potential in a Rising Biotech Star

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is capturing investor attention with its promising developments in the biotechnology sector, particularly in the realm of neurological treatments. With a market capitalization of..

CONMED Corporation (CNMD) Stock Analysis: Exploring a 13.75% Potential Upside in Healthcare’s Medical Device Sector

Investors eyeing opportunities in the healthcare sector may find CONMED Corporation (CNMD) an intriguing proposition. With a market capitalization of $1.29 billion, this American medical device company operates within the..

Certara, Inc. (CERT) Investor Outlook: Exploring a Promising 72.59% Potential Upside

Certara, Inc. (NASDAQ: CERT), a company positioned within the healthcare sector, specifically in health information services, is capturing investor interest with its compelling growth narrative and significant potential upside. Headquartered..

Tarsus Pharmaceuticals, Inc. (TARS)

⚠️ No article content returned.

..

Investor Outlook: Ascentage Pharma Group Internat (AAPG) Poised for 93.62% Upside with Strong Analyst Support

Ascentage Pharma Group International (AAPG), a clinical-stage biotechnology company based in Suzhou, China, is capturing the attention of investors with its innovative pipeline focused on cancer therapies, chronic hepatitis B,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds